FDA
approval
· 2019-10-31
FDA Approved: RANOLAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
FDA approved a supplemental application for ranolazine under Sun Pharmaceutical Industries’ ANDA211707. This approval updates the status of this generic product…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RANOLAZINE (RANOLAZINE)